In this study SOX2 was initially identified as an inducer of glioblastoma subtype transition in an experimental overexpression-screen, and subsequently SOX2 was found through a CMap analysis to be at the apex of gene expression determination in glioblastoma cultures [31, 32]. Here, SOX2 is linked to glioblastoma.